Cystic Fibrosis Foundation invests $13m in SpliSense
The investment comes following positive results in an initial efficacy trial, Phase IIa, in which an improvement in lung function ...
The investment comes following positive results in an initial efficacy trial, Phase IIa, in which an improvement in lung function ...
A 178 square meter lot in Tel Aviv’s Neve Tzedek neighborhood has been sold for NIS 13 million. Negotiations ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.